Pasithea Therapeutics Corp.

KTTA | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.51

-$0.01 (-2.62%)

At close: Sep 21, 2026, 4:00 PM ET

$0.51

$0 (+0.16%)

After-hours: Sep 21, 2026, 4:10 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-2.62%

(1D)

Rating

Updated: Sep 18, 2026

32.8

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $17.05M

1D Range

0.49 0.52

52W Range

0.28 2.06

Valuation (TTM)

PE -0.27

PB 0.00

EV/EBITDA 1,958.92

Valuation (NTM)

Forward PE N/A

Forward PEG 0.01

Price Target $3

Cash Flow

FCF Yield -104.3%

SBC Adj. FCF Yield -2457.9%

SBC Impact -2257.4%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | -100.0%

Dil EPS 3Y | 5Y 74.5% | 43.1%

FCF 3Y | 5Y -9.6% | -12.2%

Returns

ROA -41.2%

ROE -49.5%

ROIC -48.0%

Financial Health

Net Cash

$45.66B

Current Ratio 26.25

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its ...

Sector Healthcare

Industry Biotechnology

Employees 5

IPO Date Sep 14, 2021

Website www.pasithea.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 12, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+488.24%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞